Chemoresensitization of hepatocellular carcinoma via epigenetically reprogrammed carrier-free nano-epidrug
Fields of Study & Subjects
Histone Deacetylase Inhibitors Research
Nanoplatforms for cancer theranostics
RNA Interference and Gene Delivery
Publication details
- Journal / source
- Chinese Chemical Letters
- Publisher
- Elsevier BV
- Pages
- 112546–112546
- Publication date
- 1 February 2026
- Language
- EN